We, too, are facing a similar Corporate Welfare Scheme intended to defraud Missouri taxpayers.
The Taxpayer Loan to Clone ScamLink...
The truth behind the Prop 71 money grab
Did you know that adult stem cell therapies currently treat 58 different diseases in human patients, while cloning/embryonic stem cell research has produced ZERO human treatments. Not one. [1]
So why does Big Biotech want our tax dollars to fund cloning for human embryo experiments?
Why does Big Biotech exploit suffering families by relentlessly overselling the potential of cloning and destructive embryo research? [2]
FOLLOW THE MONEY . . .
Cloned Embryonic Stem Cell Research:
• Private investor dollars have severely dropped out because embryonic stem cell research produced no human treatments despite a decade and millions of dollars invested. [3]
• Thus, Big Biotech’s need for cash is the driving force in the effort to get our tax-dollars to fund cloning for human embryo research. [3a]
• Researchers and Biotech companies can patent and mass-produce cloned, embryo, and fetal stem cell lines that can be sold to drug companies and universities - at the expense of women's health. [4]
• University scientists often present themselves as objective arbiters in the cloning debate – but most have serious financial interest in the game because cloned embryonic stem cells represent the possibility of millions of dollars in patentable stem cell lines EVEN WITHOUT EVER PRODUCING A TREATMENT OR CURE! [5]
o Cloning/Embryonic Research: NO human treatments – LOTS of Cash for Big Biotech
Adult Stem Cell Treatments:
• By contrast, in many adult stem cell treatments for current patients, a person’s own adult stem cells from fat, blood or bone marrow can be used.
• Because a person’s own cells are used in medical procedures, this is generally not patentable according to patent laws since medical operations using ones own cells and tissues should be for the benefit of humanity. [6]
• Adult Stem Cells have already led to 58 human treatments -- Embryo Cloning research has led to none. [1]
o ADULT Stem Cells: MANY human treatments – Not much CashDoes Quick Cash, or Cures, drive the Cloning lobby?
Source Citations:
[1] Prentice, D. "Adult Stem Cells" Appendix K in Monitoring Stem Cell Research: A Report of the President's Council on Bioethics (Washington, DC: Government Printing Office, 2004), 309-346.
[2] Michael Hiltzik, “Potential of Stem Cells Relentlessly Oversold,” Los Angeles Times, 10/28/2004; See also, Michael Fumento, Juvenile Diabetes Foundation Loses its Way, WorldNetDaily (March 2005).
[3] David P. Hamilton, “Biotech's bottom line: More than $40 billion in losses,” Associated Press as reported in The Wall Street Journal Online, 5/20/2004.
[3a] Ed Feulner, "Tough Cell", The Washington Times, June 8, 2005.
[4] Marshall, E.(2000) “The Business of Stem Cells,” Science, 287:1419-1421; see also Neil Munroe, “The New Patent Puzzle,” National Journal, March 2, 2002.
[5] Neil Munro, “Doctor Who: Scientists are treated as objective arbiters in the cloning debate, but most have serious skin in the game,” Washington Monthly, November 2002.
[6] Senate Commerce Subcommittee on Science, Technology, and Space, Senate Testimony of Jean D. Peduzzi-Nelson, Ph.D. (July 14, 2004).
No comments:
Post a Comment